AAR ON TAXABILITY OF A CANADIAN COMPANY, HAVING NO PE IN IND


Last updated: 24 September 2008

Court :
THE AUTHORITY FOR ADVANCE RULINGS (INCOME TAX) NEW DELHI

Brief :
Where the applicant is in the business of providing bioanalytical services to various pharmaceutical companies around the world, the consideration/fee paid by the Indian pharmaceutical companies to the applicant in respect of bioequivalence tests conducted by it is in the nature of ‘business profits’ under article 7 of the Indo-Canada DTAA and the same is not taxable in India as the applicant does not have a PE in India.

Citation :
Anapharm Inc, In re: AAR NO. 746 of 2008 September 11, 2008

You have reached daily limit of 2 Free Judgements. To view this or other Judgements please subscribe to CCI PRO :

GST Plus

Stay updated! Stay ads free

Browse CAclubindia ads free.
Latest updates on WA.
Daily E-Newsletter and much more.

CCI PRO annual subscription :

Original Price : INR 2999/-

Offer Price : INR 1999/-

Duration : 1 year
(Prices Inclusive of GST)


Know More

Note: If you are a PRO member already, please click here to login (for ad free experience)
 

CCI Pro

CHEZHIYAN
Published in Income Tax
Views : 62

Comments

CAclubindia's WhatsApp Groups Link



CCI Pro
Meet our CAclubindia PRO Members

Follow us